Aluminium

Generic Name: Aluminium

Drug Type: Small Molecule

Chemical Formula: Al

CAS Number: 7429-90-5

Unique Ingredient Identifier: CPD4NFA903

Overview

A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy	2024/11/08	NCT06680479	Phase 1	Recruiting	National Institute of Allergy and Infectious Diseases (NIAID)
Safety & Immunogenicity of 426c.Mod.Core-C4b Vaccine With 3M-052-AF+Alum in Infants Perinatally Exposed to HIV But Uninfected	2024/09/26	NCT06613789	Phase 1	Not yet recruiting	HIV Vaccine Trials Network
A Clinical Trial in Adult Participants Without HIV and in Overall Good Health to Evaluate the Safety and Immunogenicity of CD4BS CH505M5 Pr-NP1 Followed by CH505 TF chTrimer Boost Both Adjuvanted With Either Lipid Nanoparticles (LNPs) or 3M-052-AF + Alum	2024/02/20	NCT06267872	Phase 1	Withdrawn	National Institute of Allergy and Infectious Diseases (NIAID)
Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIV	2023/03/23	NCT05781542	Phase 1	Completed	National Institute of Allergy and Infectious Diseases (NIAID)
In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique	2022/04/25	NCT05343312	Phase 4	Active, not recruiting	Centro de Investigacao em Saude de Manhica
Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage.	2021/11/23	NCT05131295	Phase 3	Completed	El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants.	2021/06/07	NCT04915768	Phase 1	Active, not recruiting	National Institute of Allergy and Infectious Diseases (NIAID)
Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes	2020/02/10	NCT04262479	Phase 2	Completed	Norwegian University of Science and Technology
A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine	2018/11/28	NCT03755427	Phase 2	Completed	Shanghai Institute Of Biological Products
Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2	2018/01/31	NCT03416348	Phase 1	Completed	University of Utah

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Metox	Deseret Biologicals, Inc.	43742-1312	ORAL	12 [hp_X] in 1 mL	5/27/2025
MetDetox	Dr. Donna Restivo DC	62185-0062	ORAL	12 [hp_X] in 1 mL	5/23/2025

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
MECLOSIL TABLET	SUNWARD PHARMACEUTICAL PRIVATE LIMITED	SIN10845P	TABLET	325 mg	3/25/1999
MAGNESIUM TRISILICATE COMPOUND TABLET BP	SUNWARD PHARMACEUTICAL PRIVATE LIMITED	SIN06599P	TABLET	120 mg	10/1/1991
GERSKIN TABLET	Y S P INDUSTRIES (M) SDN BHD	SIN07893P	TABLET	200 mg	10/31/1994

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
TRI-MAG-GEL B TAB	N/A	NATIONAL PHARMACEUTICAL INDUSTRIES CO.	N/A	N/A	7/23/1981
XYLMOL SUPPOSITORY	N/A	LOYAL ADVANCE LIMITED	N/A	N/A	6/29/2000

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
ALUMINIUM METALLICUM	dolisos canada inc.	02234297	Liquid , Globules , Granules - Oral	6 X	1/5/1998
ECZ HP	bio active canada ltd.	02233603	Liquid - Oral	30 X	5/26/1998
ALUMINIUM-INJEEL LIQ (D10-D200)	Biologische Heilmittel Heel Gmbh	02037017	Liquid - Oral	10 D / ML	12/31/1993
UNDA 33	seroyal international inc.	02233255	Granules , Pellet , Tablet , Drops , Liquid - Oral	12 X	4/6/1998
UNDA 18	seroyal international inc.	02233233	Liquid , Pellet , Granules , Drops , Tablet - Oral	12 X	4/6/1998
UNDA 19	seroyal international inc.	02233234	Liquid , Tablet , Granules , Drops , Pellet - Oral	12 X	4/6/1998
ALUMINIUM METALLICUM GRANULE 6DH-30DH	homeocan inc.	01932861	Tablet - Oral	6 DH	12/31/1991
UNDA 43	seroyal international inc.	02233260	Liquid , Drops , Tablet , Pellet , Granules - Oral	12 X	4/6/1998
UNDA 28	seroyal international inc.	02233249	Pellet , Drops , Liquid , Granules , Tablet - Oral	12 X	4/6/1998
ALUMINIUM METALLICUM	homeocan inc.	02233882	Globules , Drops , Granules - Oral	6 X	1/24/1998

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
AVAXIM JUNIOR SUSPENSION INYECTABLE EN JERINGA PRECARGADA	Sanofi Winthrop Industrie	85769	SUSPENSIÓN INYECTABLE EN JERINGA PRECARGADA	Medicamento Sujeto A Prescripción Médica	Not Commercialized

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

Related News

No news found

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.